Dr. Vamsi Velcheti and Dr. Benjamin Neel, of the NYU Langone Perlmutter Cancer Center, and Dr. John Heymach, of MD Anderson Cancer Center, discuss new therapeutic approaches for KRAS-mutant lung cancers and therapy options for RAS-altered tumors.
1 – 20 out of 706 Results for “2024 ASCO Genitourinary Cancers Symposium” 706 Results Select All Presenter: Mohammad Jad Moussa, MD, MSc Presenter: Chinmay…
Doctors James Ferriss, Linda Duska, and Jayanthi Lea discuss the promise and the challenges of targeting the immune system with immune checkpoint inhibitors, or ICIs,…
Volunteers from the Association for Clinical Oncology (ASCO) were on Capitol Hill on April 17 for the 2024 ASCO Advocacy Summit where they met with…
What would you do if your doctor told you they knew how to treat your cancer, but couldn’t get the medicine to do so?
What would you do if your doctor told you they knew how to treat your cancer, but couldn’t get the medicine to do so?
PURPOSE Denosumab is clinically superior to zoledronic acid (ZA) for preventing and delaying time to first and subsequent skeletal-related events (SREs) among patients with breast…
